Skip to main content
. 2019 Dec 5;13(12):e0007899. doi: 10.1371/journal.pntd.0007899

Fig 6. Toxicity profiles of snake venoms and neutralising potencies of commercial antivenoms.

Fig 6

(A) and (B) depict the median lethal doses of various medically important snakes and the neutralising potency of Premium Serums antivenom, respectively. Vertical solid and dotted lines in panel (B) indicate marketed neutralising potencies of antivenoms against N. naja (0.60 mg/mL), and B. caeruleus and E. carinatus (0.45 mg/mL), respectively.